These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 15383958

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Multiple sclerosis in the year 2000: advances in the treatment with interferon beta-1b].
    Cendrowski W.
    Neurol Neurochir Pol; 2001; 35(5):855-65. PubMed ID: 11873598
    [Abstract] [Full Text] [Related]

  • 4. PRISMS: the story of a pivotal clinical trial series in multiple sclerosis.
    Cohen BA, Rivera VM.
    Curr Med Res Opin; 2010 Apr; 26(4):827-38. PubMed ID: 20121658
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Landmark papers in multiple sclerosis.
    Cross AH.
    Neurology; 2001 Dec; 57(12 Suppl 5):S1-2. PubMed ID: 11902588
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The clinical effect of neutralizing antibodies against interferon-beta is independent of the type of interferon-beta used for patients with relapsing-remitting multiple sclerosis.
    Koch-Henriksen N, Sorensen PS, Bendtzen K, Flachs EM.
    Mult Scler; 2009 May; 15(5):601-5. PubMed ID: 19299439
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Results of a multicenter study of Rebif-22 mcg administration in Russia].
    Zavalishin IA, Gusev EI, Iakhno NN, Skoromets AA, Boĭko AN, Demina TL, Burlutskiĭ A P, Beĭn BN, Sholomov II, Pereserdova AV, Stoĭda NI, Zakharova MN, Adarcheva LS, Niiazbekova AS, Askarova LSh, Oleĭnikov VG, Rebrova OIu, Shmidt TE, Davydovskaia MV, Totolian NA, Beskhmel'nitsina IA, Bragina OV, Ponomareva GL, Durseneva OM, Voronchikhina SA, Volkova LI, Turova EL, Streknev AG.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003 May; (Spec No 2):73-8. PubMed ID: 12938639
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical course after change of immunomodulating therapy in relapsing-remitting multiple sclerosis.
    Caon C, Din M, Ching W, Tselis A, Lisak R, Khan O.
    Eur J Neurol; 2006 May; 13(5):471-4. PubMed ID: 16722971
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.